20 reports

  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, LICENSING DEALS, 2006-2017 (PART 2)
  • DERMATOLOGY THERAPEUTICS MARKET, GLOBAL, LICENSING DEALS, 2006-2017 (PART 3)

Phase II Small molecule LP-## LEO Pharma A/ S Accolade Pharmaceuticals LLC Phase II Undisclosed Undisclosed Cysteinyl Leukotriene Receptor ## (Cysteinyl Leukotriene D## Receptor or G Protein Coupled R Zafi-## Phase II Small molecule t HG## HMTMF## CYSLTR##) AQ-##

  • Dermatological Condition
  • Dermatology
  • Pharmaceutical
  • Therapy
  • Biopharmaceuticals Inc.

Company and Teva Pharmaceuticals.

  • Pharmaceutical
  • Skin Cancer
  • World
  • Market Size
  • Biopharmaceuticals Inc.
  • Keryx Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018
  • Keryx Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Summary Keryx Biopharmaceuticals Inc (Keryx) develops and commercializes new therapies for the treatment of renal disease.The company’s lead product Auryxia (ferric citrate) is an FDA approved oral, absorbable iron-based phosphate binder, which helps lower the amount of phosphate in human blood. Auryxia is used in...

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Demand
  • Biopharmaceuticals Inc.
  • TEVA PHARMA ENTERS INTO LICENSING AGREEMENT WITH ALDER BIOPHARMA
  • ALDER BIOPHARMACEUTICALS INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2012 TO YTD 2018

Summary Alder Biopharmaceuticals Inc (Alder) is a biopharmaceutical company which develops, produces and markets monoclonal antibody therapeutics for the treatment of migraine, Cushing’s disease and autoimmune and inflammatory diseases.The company uses technologies such as the antibody selection system and novel mab xpress...

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Company
  • Biopharmaceuticals Inc.
  • Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018
  • Navidea Biopharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018

Summary Navidea Biopharmaceuticals Inc (Navidea) is a biopharmaceutical company that develops precision immunodiagnostic agents and immunotherapeutics.. The company is focused on developing multiple precision-targeted products based on its Manocept platform to improve patient care. Its pipeline products include MT-1002;...

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Company
  • Biopharmaceuticals Inc.

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2016 Social Media Advertising Spend in China, 2016 Databook List of Figures List of Tables ##.

  • Advertising
  • Computer
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Brands pay for space on one or more of the online company' s pages to display a static or linked banner or logo.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd

REFERENCE CODE: SMDB## PUBLISHED: APRIL 2015 Social Media Advertising Spend in China, 2015 Databook List of Figures List of Tables ##.

  • Advertising
  • Marketing
  • Pharmaceutical
  • Social Network
  • Tencent Holdings Ltd

Digital Advertising Spend in China, 2015 Databook REFERENCE CODE: DSDB## PUBLISHED: APRIL 2015 LIST OF FIGURES LIST OF TABLES ##.

  • Advertising
  • Computer
  • Online Advertising
  • Pharmaceutical
  • Tencent Holdings Ltd

Hoffmann-La Roche Ltd. ## ## ## ## ## ## ## ## AstraZeneca PLC ## ## ## ## ## ## ## ## Pfizer Inc. ## ## ## ## ## ## ## ## Sanofi ## ## ## ## ## ## ## ## Shire Plc ## ## ## ## ## ## ## ## Merck & Co., Inc. ## ## ## ## ## ## ## ## Baxter International Inc. ## ##

  • Clinical Trial
  • Hospital
  • Pharmaceutical
  • Renal Disease
  • Biopharmaceuticals Inc.
  • KERYX BIOPHARMACEUTICALS INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2012 TO YTD 2018
  • KERYX BIOPHARMACEUTICALS INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2012 TO YTD 2018

Keryx Biopharmaceuticals Inc (KERX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities...

  • Pharmaceutical
  • United States
  • Company Financials
  • Demand
  • Biopharmaceuticals Inc.
  • Section 4 - Company's, Lifesciences Financial Deals and Alliances
  • Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results

Navidea Biopharmaceuticals Inc (NAVB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations.The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities...

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Company Financials
  • Biopharmaceuticals Inc.
  • ALDER BIOPHARMACEUTICALS INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY TYPE, 2012 TO YTD 2018
  • ALDER BIOPHARMACEUTICALS INC, PHARMACEUTICALS & HEALTHCARE, DEALS BY YEAR, 2012 TO YTD 2018

Alder Biopharmaceuticals Inc (ALDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities...

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Company Financials
  • Biopharmaceuticals Inc.
  • Industry
  • Ipsen Biopharmaceuticals Inc - Key Competitors

Ipsen Biopharmaceuticals Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This up-to-the-minute...

  • Pharmaceutical
  • United States
  • Company
  • Demand
  • Biopharmaceuticals Inc.
  • Nov 08, 2017: Navidea Biopharmaceuticals Reports Third Quarter 2017 Financial Results

The term sheet includes a standstill provision that halts the litigation initiated by Sinotau Pharma against Navidea if the parties execute a definitive agreement within ## days.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Company
  • Biopharmaceuticals Inc.
  • PARTNERSHIP
  • PARTNERSHIP - DEAL REPORTS

Company information: Partners Partner ##: Hainan Sinotau Pharmaceutical Co., Ltd.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Biopharmaceuticals Inc.
  • PRIVATE EQUITY AND OWNERSHIP - DEAL REPORTS

Cumberland House, ## Victoria Street, ##th Floor Hamilton Bermuda www. celticpharma. com ## ## ## ## Company information: Partners Partner ##: Celtic Pharmaceutical Holdings L. P.

  • Pharmaceutical
  • United States
  • Company Financials
  • Corporate Finance
  • Biopharmaceuticals Inc.
  • PARTNERSHIP - DEAL REPORTS

Pharmaceuticals and Healthcare--> Pharmaceuticals-- > Pharmaceutical Manufacturers Pharmaceuticals and Healthcare--> Pharmaceuticals-- > Pharmaceutical Manufacturers--> Over-the-Counter Medicines (OTC) Company information: Partners Part

  • Pharmaceutical
  • Japan
  • United States
  • Corporate Finance
  • Biopharmaceuticals Inc.
  • PRIVATE EQUITY & OWNERSHIP
  • PARTNERSHIP

Pharmaceuticals and Healthcare--> Pharmaceuticals-- > Pharmaceutical Manufacturers Pharmaceuticals and Healthcare--> Medical Devices and Diagnostics Pharmaceuticals and Healthcare--> Therapy Area--> Central Nervous System--> Neurology

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Biopharmaceuticals Inc.

Global Markets Direct aims to cover major news events and deals in the pharmaceutical industry, updated on daily basis.

  • Biopharmaceutical
  • Pharmaceutical
  • United States
  • Company Operations
  • Biopharmaceuticals Inc.